What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Immune system
Richard J. O'Reilly spends much of his time researching Immunology, Transplantation, Bone marrow, Internal medicine and Leukemia.
His work deals with themes such as Immunosuppression, Severe combined immunodeficiency and Histocompatibility, which intersect with Transplantation.
He interconnects Haematopoiesis, Cyclophosphamide, Absolute neutrophil count and Immunity in the investigation of issues within Bone marrow.
His Internal medicine research incorporates elements of Gastroenterology, Surgery and Oncology.
His Leukemia research is multidisciplinary, incorporating perspectives in Myeloid and Marrow transplantation.
His study in Human leukocyte antigen is interdisciplinary in nature, drawing from both Cytotoxic T cell and Virology.
His most cited work include:
- Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation (936 citations)
- Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts (831 citations)
- Cytomegalovirus Pneumonia after Bone Marrow Transplantation Successfully Treated with the Combination of Ganciclovir and High-Dose Intravenous Immune Globulin (411 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Immunology, Transplantation, Hematopoietic stem cell transplantation and Gastroenterology.
Richard J. O'Reilly combines subjects such as Surgery and Oncology with his study of Internal medicine.
His Immunology course of study focuses on Cytotoxic T cell and CD8 and Molecular biology.
Richard J. O'Reilly works mostly in the field of Transplantation, limiting it down to topics relating to CD34 and, in certain cases, Hematopoietic cell.
He has included themes like Incidence, Severe combined immunodeficiency and Multiple myeloma in his Hematopoietic stem cell transplantation study.
His Gastroenterology research integrates issues from Myeloid, Neutrophil Engraftment and Acute leukemia.
He most often published in these fields:
- Internal medicine (54.35%)
- Immunology (45.65%)
- Transplantation (49.41%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (54.35%)
- Transplantation (49.41%)
- Oncology (22.13%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Transplantation, Oncology, CD34 and Gastroenterology.
The concepts of his Transplantation study are interwoven with issues in Ex vivo, Hematopoietic cell, Immunology, Cord blood and T cell.
His Immunology research is multidisciplinary, incorporating elements of Cytotoxic T cell and Cell therapy.
His studies in Oncology integrate themes in fields like Cancer, Transplantation outcomes, Pathology and Rituximab.
His research in Gastroenterology intersects with topics in Progression-free survival, Myeloid, Graft-versus-host disease, Bone marrow and Acute leukemia.
His Hematopoietic stem cell transplantation research incorporates themes from Retrospective cohort study, Leukemia and Severe combined immunodeficiency.
Between 2016 and 2021, his most popular works were:
- Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. (101 citations)
- SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery (65 citations)
- Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL (49 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Immune system
The scientist’s investigation covers issues in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Ex vivo and Oncology.
His Internal medicine research includes elements of Gastroenterology, CD34 and Surgery.
His biological study spans a wide range of topics, including Calcineurin, Cumulative incidence and Bone marrow.
His work deals with themes such as Myeloid and Incidence, which intersect with Transplantation.
His studies deal with areas such as Severe combined immunodeficiency and Leukemia, Immunology, Immune system as well as Hematopoietic stem cell transplantation.
Richard J. O'Reilly is studying T cell, which is a component of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
